Breast cancer cells can also acquire resistance to paclitaxel by switching from apoptosis to autophagy, which results in downregulation of the mammalian target of rapamycin (mTOR) pathway along with an increased ability of breast cancer cells to survive under stress conditions [29]. The gene discussed is MTOR; the disease is breast carcinoma.